MoonLake Immunotherapeutics revenue growth has been varied year-over-year.

What is MLTX's revenue growth rate?

Historical revenue data is available for MoonLake Immunotherapeutics to analyze growth trends.

How fast is MLTX earnings growing?

Earnings growth data is available for MoonLake Immunotherapeutics analysis.

What is MLTX's profit margin?

Profit margin data is available for MoonLake Immunotherapeutics.

MLTX Revenue & Earnings Growth Analysis 2026 - Is MoonLake Immunotherapeutics Growing?

Growth Summary

MoonLake Immunotherapeutics (MLTX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.

Latest Revenue

$0.00

Net Income

$-121244400.00

5-Year Revenue CAGR

N/A

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for MoonLake Immunotherapeutics

The chart above illustrates MoonLake Immunotherapeutics's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of MoonLake Immunotherapeutics's business.

Profit Margin Trends

How efficiently MoonLake Immunotherapeutics converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue MoonLake Immunotherapeutics retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$-3.60

Current: $-1.89

EPS Estimate 2027

$-3.76

4.4% expected growth

Price Target

$18.63

Analyst consensus

What Analysts Are Saying

Wall Street analysts project MoonLake Immunotherapeutics to continue focusing on sustainable operations. The consensus analyst rating is 4.75 based on 16 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, MoonLake Immunotherapeutics (MLTX) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:
Profitability: shows the company is investing in growth over short-term profits
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of MoonLake Immunotherapeutics's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.